153 related articles for article (PubMed ID: 16495030)
21. A rapid quantitative assay for the detection of mammalian heparanase activity.
Freeman C; Parish CR
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):229-37. PubMed ID: 9224651
[TBL] [Abstract][Full Text] [Related]
22. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
23. Evidence that platelet and tumour heparanases are similar enzymes.
Freeman C; Browne AM; Parish CR
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
[TBL] [Abstract][Full Text] [Related]
24. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
25. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
26. Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.
McKenzie E; Young K; Hircock M; Bennett J; Bhaman M; Felix R; Turner P; Stamps A; McMillan D; Saville G; Ng S; Mason S; Snell D; Schofield D; Gong H; Townsend R; Gallagher J; Page M; Parekh R; Stubberfield C
Biochem J; 2003 Jul; 373(Pt 2):423-35. PubMed ID: 12713442
[TBL] [Abstract][Full Text] [Related]
27. A homogeneous time-resolved fluorescence detection of telomerase activity.
Gabourdes M; Bourgine V; Mathis G; Bazin H; Alpha-Bazin B
Anal Biochem; 2004 Oct; 333(1):105-13. PubMed ID: 15351286
[TBL] [Abstract][Full Text] [Related]
28. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
29. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
30. A homogeneous time-resolved fluorescence resonance energy transfer assay for phosphatidylserine exposure on apoptotic cells.
Gasser JP; Hehl M; Millward TA
Anal Biochem; 2009 Jan; 384(1):49-55. PubMed ID: 18835236
[TBL] [Abstract][Full Text] [Related]
31. Allophycocyanin 1 as a near-infrared fluorescent tracer: isolation, characterization, chemical modification, and use in a homogeneous fluorescence resonance energy transfer system.
Trinquet E; Maurin F; Préaudat M; Mathis G
Anal Biochem; 2001 Sep; 296(2):232-44. PubMed ID: 11554719
[TBL] [Abstract][Full Text] [Related]
32. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
33. A flow injection kinase assay system based on time-resolved fluorescence resonance energy-transfer detection in the millisecond range.
Hirata J; de Jong CF; van Dongen MM; Buijs J; Ariese F; Irth H; Gooijer C
Anal Chem; 2004 Aug; 76(15):4292-8. PubMed ID: 15283563
[TBL] [Abstract][Full Text] [Related]
34. Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase.
Lai NS; Simizu S; Morisaki D; Muroi M; Osada H
Exp Cell Res; 2008 Sep; 314(15):2834-45. PubMed ID: 18662687
[TBL] [Abstract][Full Text] [Related]
35. Colorimetric heparinase assay for alternative anti-metastatic activity.
Ahn SC; Kim BY; Oh WK; Park YM; Kim HM; Ahn JS
Life Sci; 2006 Sep; 79(17):1661-5. PubMed ID: 16806278
[TBL] [Abstract][Full Text] [Related]
36. Use of a phosphotyrosine-antibody pair as a general detection method in homogeneous time-resolved fluorescence: application to human immunodeficiency viral protease.
Cummings RT; McGovern HM; Zheng S; Park YW; Hermes JD
Anal Biochem; 1999 Apr; 269(1):79-93. PubMed ID: 10094778
[TBL] [Abstract][Full Text] [Related]
37. Heparanase processing by lysosomal/endosomal protein preparation.
Cohen E; Atzmon R; Vlodavsky I; Ilan N
FEBS Lett; 2005 Apr; 579(11):2334-8. PubMed ID: 15848168
[TBL] [Abstract][Full Text] [Related]
38. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
39. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of a tetrasaccharide substrate of heparanase.
Chen J; Zhou Y; Chen C; Xu W; Yu B
Carbohydr Res; 2008 Nov; 343(17):2853-62. PubMed ID: 18619582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
